HAI-ROBOTICS
10.1.2022 09:02:10 CET | Business Wire | Press release
HAI ROBOTICS , a global leader in Autonomous Case-handling Robotic (ACR) system for warehouse logistics, announced that it has entered a strategic partnership with Greece's market leader in intralogistics, Voyatzoglou Systems , in a joint effort to offer more smart warehousing solutions to the supply chain in Greece and the Balkan area. The alliance marked the third the company has ever concluded in Europe as it keeps securing more footholds in the global intralogistics market.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220110005066/en/
HAI ROBOTICS has gained extensive customer recognition with its warehousing automation solution HAIPICK ACR system running on more than 300 projects both in China and abroad. The system, independently developed as early as 2015, features flexible deployment and improved efficiency for warehouses that seek to maximize their storage spaces.
The HAIPICK robots, built with multiple sensors capable of integrated positioning, boasts a good control precision of ±3mm to allow intelligent picking, transport, auto-navigation, obstacle avoidance and auto-charging with high stability and high-accuracy. The HAIPICK robots can pick and place totes or cartons on storage shelves up to 10 meters high and are able to carry up to 8 loads to continuously feed goods-to-person picking stations. The newest invention of a fork-lifting robot is compatible with wider storage scenarios in which goods are not necessarily placed inside a box, such as tires and trays.
Kane Luo, Vice President of Sales from HAI ROBOTICS, said that the two parties are expected to complement each other by combining one side's project operation experience with localized service network of another. "We're impressed by the Voyatzoglou Systems' local service ability in the Balkan region. Our rich experience in automation solutions for a wide variety of sectors, from retail to 3PL and manufacturing plants, will be grafted onto local supply chain to improve efficiency and investment returns," he said, and added that all the HAIPICK ACR series have obtained the CE Mark, meeting European quality and safety standards.
“The partnership with HAI ROBOTICS allows us to extend our product portfolio by offering technologically state of the art and innovative solutions for material handling and goods to person. We believe that this collaboration will generate projects in automated warehouses, provide solid solutions to many of our customers seeking Autonomous Case-handling Robotic (ACR) systems and advance the market further," said Mrs. Annie Voyatzoglou, deputy CEO of Voyatzoglou Systems.
About Voyatzoglou
Voyatzoglou Systems is among the leading organizations in the Intralogistics and Shop Fitting sector in Greece, with a history of over 30 years. Cornerstone of their success are their strong operations, wide product portfolio with leading manufacturing companies and solid customer relationships. Voyatzoglou company caters to a wide range clientele, from large retail chains to 3PL companies and manufacturing plants. The last years Voyatzoglou Systems group of companies (both in Greece and Romania) have extended their activities from simple traditional warehouse shelving to automated and generally smart Logistics solutions. They have successfully delivered automated projects of high value to customers in Greece and the wide Balkan area.
Voyatzoglou Systems is a publicly traded company in the Greek Stock exchange, with a turnover of about 30 million euros, it employees more than 180 people and has its main premises in Athens Greece – with branch offices in Northern Greece and in Bucharest Romania through its subsidiary company Voyatzoglou Systems Romania SRL.
About HAI ROBOTICS
HAI ROBOTICS, a trailblazer of Autonomous Case-handling Robotic (ACR) system, is committed to providing efficient, intelligent, flexible, and customized warehouse automation solutions through robotics technology and AI algorithms. It aims to create value for each factory and logistics warehouse.
The HAIPICK ACR system, independently developed in 2015, is the world's first of its kind.
Founded in 2016 with headquarters in Shenzhen, China, HAI ROBOTICS has set up five subsidiaries in Hong Kong SAR, Japan, Singapore, the U.S. and the Netherlands, serving customers from more than 30 countries and regions. It now has over 1,300 staff, more than 50% of whom are engineers. The company has acquired more than 600 global patents for core intellectual properties involving positioning, robot control and warehouse management. In the latest C and D rounds of funding in 2021, the company raised over US$200 million in total.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005066/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom